AGEP (Acute Generalised Exanthematous Pustulosis) Diagnosis & Management in London

What Is AGEP?

Acute Generalised Exanthematous Pustulosis (AGEP) is an uncommon, short-lived but striking skin eruption most often triggered by medicines. It presents with a sudden shower of tiny, superficial sterile pustules on a red, tender background. People may feel feverish, shivery or “fluey”, and blood tests often show a temporary rise in white cells (neutrophils). The eruption usually starts on the face, neck or body folds and then spreads across large areas within 24–48 hours. When the reaction settles, the pustules dry and the skin commonly peels in fine sheets, similar to a sunburn peel. With prompt recognition, withdrawal of the culprit drug and supportive care, recovery is expected.

How Quickly Does AGEP Start?

AGEP typically begins within hours to a few days of starting a new medicine or after a single dose of an antibiotic. In people previously sensitised to a trigger, the reaction can be even faster. Less commonly, certain viral or bacterial infections can precipitate a similar picture. Because timing is crucial, we always construct a careful timeline of the days and weeks preceding the eruption, including prescriptions, over-the-counter remedies, herbal products and any recent infections.

Common Triggers for AGEP

Many drug classes can provoke AGEP. Those most often implicated include some antibiotics (e.g., beta-lactams, macrolides), certain antifungals, antimalarials (e.g., hydroxychloroquine), and calcium-channel blockers. Painkillers, contrast agents and other drugs have also been reported. Importantly, the same medicine may be safe for most people yet trigger AGEP in a particular individual. We therefore avoid blanket lists and focus on your personal timeline and exposure history.

What AGEP Feels and Looks Like

• Skin: hundreds of pin-head pustules on red, tense skin; the pustules are non-follicular (not centred on hairs) and superficial.
• Symptoms: burning or stinging rather than intense itch; tightness; sometimes swelling of hands/face.
• Systemic features: fever, malaise, mild lymph-node swelling; laboratory neutrophilia is common; liver or kidney blood tests are usually normal or show mild, transient change.
• Course: the eruption evolves rapidly, then begins to settle a few days after the suspected drug is withdrawn. Fine peeling follows.

AGEP vs Other Severe Drug Reactions

Several conditions can mimic AGEP and need careful distinction:

• Pustular psoriasis: can look similar but often has a history of psoriasis, more persistent plaques and may not be closely linked to a new drug.
• DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms): usually starts later (2–8 weeks after a drug), with facial swelling, widespread rash, high eosinophils and organ involvement.
• SJS/TEN (Stevens–Johnson syndrome/toxic epidermal necrolysis): painful skin with blisters and erosions, mouth/eye involvement and systemic illness; this is an emergency and looks/behaves differently from AGEP.
• Infections: bacterial or viral rashes with pustules; swabs and clinical context help differentiate.

Making the correct distinction guides treatment and follow-up. If features suggest a more serious reaction, hospital assessment is advised.

When to Seek Urgent Assessment

Call promptly for advice if you develop a sudden widespread pustular rash, particularly if you have fever or feel unwell, after starting a new medicine. Immediate attention is important if there is mouth/eye/genital soreness, large areas of skin detaching, high fever, severe pain or confusion. These red flags may indicate a different severe reaction requiring hospital care.

How We Diagnose AGEP

Diagnosis is usually clinical, supported by history and tests:

• Timeline: we map the onset in relation to drugs and infections.
• Examination: distribution, morphology (tiny, non-follicular pustules), and areas of skin tenderness are documented.
• Blood tests: full blood count (often shows neutrophilia), inflammatory markers, and baseline liver/kidney function to monitor safety.
• Swabs: may be taken from pustules to confirm they are sterile and to rule out infection if needed.
• Biopsy: occasionally performed if the diagnosis is uncertain; shows hallmark superficial (subcorneal) pustules with a neutrophil-rich infiltrate.

Treatment: Calm, Support, Prevent Recurrence

1) Identify and Stop the Likely Trigger

Where a medicine is suspected, it is usually stopped and an alternative considered. We coordinate this with your wider healthcare team, especially for essential drugs. Do not re-start the suspected trigger unless a clinician advises it is safe to do so after careful review.

2) Symptom Relief and Skin Care

• Topical corticosteroids reduce redness, tenderness and burning; soothing emollients support the barrier.
• Antihistamines help with itch or sleep disturbance where present.
• Hydration and temperature control: drink regularly; light clothing and a cool environment reduce discomfort.
• Pain/fever relief: tailored to your medical history; we avoid drugs suspected of causing the reaction.

3) When Are Tablets or Admission Needed?

Most people improve with supportive care and topical treatment. Short courses of systemic corticosteroids may be considered for extensive or very symptomatic eruptions once infection is excluded. Admission is advised if there are systemic concerns (e.g., dehydration, significant fever, widespread pain, laboratory abnormalities) or uncertainty about the diagnosis. In hospital, fluids, temperature control and closer monitoring accelerate recovery and safeguard against complications.

4) Aftercare as Skin Peels

As the eruption settles, the skin often peels in fine sheets. Continue emollients liberally and avoid exfoliation devices or scrubs. Mild pinkness or transient pigment change may persist for weeks; sun protection helps tone even out.

Recovery Timeline

Once the trigger is withdrawn, patients commonly notice improvement within a few days. Most eruptions resolve over 1–2 weeks, with peeling following soon after. Fatigue can linger briefly. We arrange review to ensure the skin is healing, update your medicines record and provide documentation for future care.

Future Safety: Avoidance and Documentation

• Medicines list: we provide a clear written record naming the suspected trigger(s) and potential cross-reactors where relevant.
• Alerting other clinicians: share your record with your GP, dentist, pharmacist and any treating specialists; consider carrying a wallet card.
• Allergy testing: delayed-reading patch tests or other specialist tests may be discussed weeks after recovery for selected drugs to support future decisions. These are organised cautiously and are not needed for everyone.

Special Groups

Children

AGEP can occur in children, often after antibiotics. The course and management are similar, with added focus on hydration and comfort. We work closely with paediatric services if hospital care is required.

Pregnancy

Supportive care and trigger withdrawal remain the cornerstones. Medicine choices for symptom relief are carefully selected for safety in pregnancy, and we liaise with obstetric teams as needed.

Skin of Colour

The pustular phase looks similar across skin tones; residual post-inflammatory hyperpigmentation may be more visible in darker skin. Gentle routines and sun protection help evenness return without provoking further irritation.

Is AGEP Contagious?

No. The pustules are sterile, and the reaction is an individual immune response to a trigger, most commonly a medicine. Close contacts are not at risk from your skin.

Returning to Daily Activities

Many people feel able to resume light activities once fever settles and discomfort is controlled. Because heat can worsen symptoms, it is sensible to avoid saunas, hot yoga and intense exercise until the skin is comfortable. Choose loose, breathable clothing while peeling settles. For work or school notes, we can provide supportive documentation.

Why Choose Skinhorizon?

We provide high-quality advanced dermatology with consultant oversight, rapid triage for acute rashes and a calm, structured approach. Our priorities are: prompt differentiation from other serious reactions, safe withdrawal strategies, effective symptom control, and clear documentation to protect you in future. You will leave with written guidance, contact routes for concerns and a plan for review.

Your First Visit — What to Expect

1. History and timeline: medicines, supplements and recent infections mapped day-by-day.
2. Examination: distribution, morphology and assessment of systemic features.
3. Investigations: targeted blood tests; swabs; biopsy only if needed.
4. Immediate plan: suspected trigger withdrawal (co-ordinated with prescriber), symptom relief, clear home-care.
5. Safety net: written red-flag advice and an accessible review pathway; documentation for your health records and pharmacy.